|
Dr. Starr is a co-founder Chief Executive Officer and a director of Raptor since its inception in 2006. Dr. Starr co-founded BioMarin Pharmaceutical Inc. in 1997 where he last served as Senior Vice President and Chief Scientific Officer. As Senior Vice President at BioMarin Dr. Starr was responsible for managing a Scientific Operations team of 181 research process development manufacturing and quality personnel through the successful development of commercial manufacturing processes for its enzyme replacement products and supervised the cGMP design construction and licensing of a manufacturing facility.
From 1991 to 1998 Dr. Starr supervised research and commercial programs at BioMarin's predecessor company Glyko Inc. where he served as Vice President of Research and Development. At Glyko Inc. Dr. Starr directed the research and development and commercial operations of the organization. Prior to his tenure at Glyko Inc. Dr. Starr was a National Research Council Associate at the National Institute of Health studying nuclear membrane transport cell surface receptor function and protein intracellular trafficking. Dr. Starr earned a B.S. from Syracuse University and a Ph.D. in Biochemistry and Molecular Biology from the State University of New York Health Science Center in Syracuse New York. | 